Gaming and Leisure Properties Inc. Common Stock vs Twist Bioscience Corp — how do they compare? Gaming and Leisure Properties Inc. Common Stock trades at $38.13 (market cap $11.15B), while Twist Bioscience Corp trades at $146.3 (market cap $10.03B). The key difference: Gaming and Leisure Properties Inc. Common Stock and Twist Bioscience Corp are close in size by market cap, and Gaming and Leisure Properties Inc. Common Stock pays a 8.56% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gaming and Leisure Properties Inc. Common Stock for 0 Days and Twist Bioscience Corp for 27 Days on average.
| GLPI | TWST | |
|---|---|---|
Market Cap | $11.15B | $10.03B |
Volume | 1,865,490 | 1,528,940 |
Sector | Real Estate | Health |
52-Week High | $49.82 | $205.00 |
52-Week Low | $37.59 | $25.45 |
Typical Hold Time | 0 Days | 27 Days |
Enterprise Value | $19.21B | $9.96B |
Dividend Yield | 8.56% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TWST trades at $148.16, down 2.44% today, with a bullish technical signal but negative earnings trends. Recent news highlights its role in Eli Lilly's AI drug discovery platform, driving investor optimism. Revenue growth is strong, reaching $376.57M in 2025, but net losses persist, with a margin of -20.63%. The stock faces resistance near $154, with support at $146.
Outlook is mixed: analyst consensus is bullish with a $153.70 price target, but profitability challenges and cash flow deficits pose risks. The AI collaboration offers growth potential, yet execution and margin improvement are critical for sustained upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Gaming and Leisure Properties Inc. is a real estate investment trust that acquires, finances, and owns casino and gaming properties, which it leases to gaming operators under triple-net lease arrangements. It was the first publicly traded REIT focused on the gaming real estate sector in North America.
Read more on GLPI →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →